Literature DB >> 19519322

The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target.

Yonghui Yu1, Yu Wan, Chuanshu Huang.   

Abstract

Nuclear factor-kappaB (NF-kappaB) is a key transcriptional factor family that consists of five members in mammalian cells, including NF-kappaB1 (p50), NF-kappaB2 (p52), RelA (p65), RelB and c-Rel. NF-kappaB is implicated in multiple physiological and pathological processes, including cell proliferation and differentiation, inflammatory and immune response, cell survival and apoptosis, cellular stress reactions and tumorigenesis. Recent studies by our group and others have highlighted the novel functions of the p50 protein. In this review, we will focus on the regulation and functions of NF-kappaB p50.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519322      PMCID: PMC3747820          DOI: 10.2174/156800909788486759

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  68 in total

Review 1.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

2.  Coordination of JNK1 and JNK2 is critical for GADD45alpha induction and its mediated cell apoptosis in arsenite responses.

Authors:  Dongyun Zhang; Lun Song; Jingxia Li; Kangjian Wu; Chuanshu Huang
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

Review 3.  Integrating cell-signalling pathways with NF-kappaB and IKK function.

Authors:  Neil D Perkins
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

4.  p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.

Authors:  Alessandra Saccani; Tiziana Schioppa; Chiara Porta; Subhra K Biswas; Manuela Nebuloni; Luca Vago; Barbara Bottazzi; Mario P Colombo; Alberto Mantovani; Antonio Sica
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

Review 5.  The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.

Authors:  A A Beg; A S Baldwin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

6.  The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.

Authors:  G P Nolan; T Fujita; K Bhatia; C Huppi; H C Liou; M L Scott; D Baltimore
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

8.  IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response.

Authors:  Lun Song; Jingxia Li; Dongyun Zhang; Zheng-Gang Liu; Jianping Ye; Qimin Zhan; Han-Ming Shen; Matt Whiteman; Chuanshu Huang
Journal:  J Cell Biol       Date:  2006-11-20       Impact factor: 10.539

9.  Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus.

Authors:  V Blank; P Kourilsky; A Israël
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.

Authors:  Y Yamaguchi; T Suda; J Suda; M Eguchi; Y Miura; N Harada; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  34 in total

Review 1.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

2.  A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases the risk of papillary thyroid carcinoma.

Authors:  Xunli Wang; Hong Peng; Yundan Liang; Ruifen Sun; Tao Wei; Zhihui Li; Yanping Gong; Rixiang Gong; Feng Liu; Lin Zhang; Jingqiang Zhu
Journal:  Genet Test Mol Biomarkers       Date:  2015-02-18

3.  Co-stimulatory CD28 and transcription factor NFKB1 gene variants affect idiopathic recurrent miscarriages.

Authors:  Maneesh Kumar Misra; Bharti Singh; Aditi Mishra; Suraksha Agrawal
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

4.  AKAP4 mediated tumor malignancy in esophageal cancer.

Authors:  Shujun Li; Xuebo Qin; Yanjie Li; Anrui Guo; Liguo Ma; Fang Jiao; Song Chai
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 5.  Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

6.  NF-κB p65 phosphorylated at serine-536 is an independent prognostic factor in Swedish colorectal cancer patients.

Authors:  Andreas Lewander; Jinfang Gao; John Carstensen; Gunnar Arbman; Hong Zhang; Xiao-Feng Sun
Journal:  Int J Colorectal Dis       Date:  2011-11-22       Impact factor: 2.571

7.  Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.

Authors:  Susan R Mallery; Daren Wang; Brian Santiago; Ping Pei; Steven P Schwendeman; Kari Nieto; Richard Spinney; Meng Tong; George Koutras; Brian Han; Andrew Holpuch; James Lang
Journal:  Cancer Prev Res (Phila)       Date:  2016-10-18

8.  The association between NFKB1-94ins/del ATTG polymorphism and non-small cell lung cancer risk in a Chinese Han population.

Authors:  Yue Wang; Libo Chen; Liming Pan; Jinru Xue; Haixiang Yu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.

Authors:  Qingqing Cai; Meifeng Tu; Zijun Y Xu-Monette; Ruifang Sun; Ganiraju C Manyam; Xiaolu Xu; Alexander Tzankov; Eric D Hsi; Michael B Møller; L Jeffrey Medeiros; Chi Young Ok; Ken H Young
Journal:  Mod Pathol       Date:  2017-03-10       Impact factor: 7.842

10.  NF-κB1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1.

Authors:  Y Yu; D Zhang; H Huang; J Li; M Zhang; Y Wan; J Gao; C Huang
Journal:  Oncogene       Date:  2013-02-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.